Skip to main content

​Botox maker Allergan to buy Kythera for $2.1 billion

Botox maker Allergan plc has agreed to acquire Kythera Biopharmaceuticals Inc., developer of a treatment for double chins, for $2...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.